Clinical Trial Update: Maintaining Antiviral Efficacy After Switching to Generic Entecavir 1 mg for Chronic Hepatitis B [Phase 4]

View source ↗

Summary

Phase 4 trial update examining maintaining antiviral efficacy after switching to generic entecavir 1 mg for chronic hepatitis B.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Entecavir 1 mg (entecavir)

Snippet

Sponsor: Korea University | Conditions: Chronic Hepatitis B | Phase 4 | Status: UNKNOWN